| 2005 |
BRIT1/MCPH1 is required for activation of both the intra-S and G2/M DNA damage checkpoints; it is a chromatin-associated protein that forms irradiation-induced nuclear foci colocalizing with γ-H2AX, and is required for expression of BRCA1 and Chk1 and phosphorylation of Nbs1. |
RNAi knockdown, nuclear foci immunofluorescence, Western blot, cell cycle checkpoint assays after ionizing radiation |
Proceedings of the National Academy of Sciences of the United States of America |
High |
16217032
|
| 2006 |
BRIT1/MCPH1 forms nuclear foci within minutes of irradiation that colocalize with 53BP1, MDC1, NBS1, ATM, RPA, and ATR; BRIT1 is required for activation of these proximal DNA damage response elements; its depletion increases chromosomal aberrations. |
Immunofluorescence foci colocalization, RNAi depletion, metaphase spread chromosomal aberration assay |
Cancer cell |
High |
16872911
|
| 2006 |
Premature chromosome condensation (PCC) in G2 and delayed decondensation in MCPH1-deficient patient cells is mediated by condensin II; siRNA depletion of condensin II subunits (but not condensin I) rescues the condensation defects in MCPH1 patient cells. |
siRNA depletion of condensin subunits in MCPH1 patient cells, cell cycle analysis |
Cell cycle (Georgetown, Tex.) |
High |
16434882
|
| 2007 |
MCPH1 is recruited to DNA double-strand break sites via its C-terminal tandem BRCT domains binding phosphorylated H2AX (γH2AX); this recruitment is H2AX-dependent but MDC1-independent; MCPH1 binds a phospho-H2AX peptide in vitro with affinity similar to MDC1. |
In vitro phospho-peptide binding assay, foci formation in H2AX-/- and MDC1-depleted cells, BRCT domain mutant analysis |
The Journal of biological chemistry |
High |
17925396
|
| 2007 |
In chicken DT40 cells, MCPH1 N-terminal BRCT1 domain is required for centrosomal localization throughout the cell cycle, while C-terminal tandem BRCT2/BRCT3 domains are required for ionizing radiation-induced nuclear foci formation via interaction with γ-H2AX. |
Domain deletion mutant analysis, immunofluorescence, foci formation in ATM/Brca1/H2AX-deficient cells |
Oncogene |
High |
17599047
|
| 2007 |
Drosophila MCPH1 is required for genomic stability in early embryo S-M cycles; loss of mcph1 causes mitotic arrest with barrel-shaped spindles and chromatin bridging; Chk2 mutation suppresses these defects, placing MCPH1 upstream of Chk2-mediated checkpoint. |
Drosophila genetic screen, null mutant analysis, epistasis with Chk2 mutation, live imaging |
Journal of cell science |
High |
17895362
|
| 2008 |
MCPH1 physically associates with the Condensin II complex; this interaction is mediated by the CAPG2 subunit of Condensin II binding to a middle domain (residues 376–485) of MCPH1; this interaction is required for homologous recombination repair. |
Co-immunoprecipitation, domain mapping, siRNA depletion, HR repair assay in MCPH1-/- MEFs |
The Journal of biological chemistry |
High |
18718915
|
| 2008 |
MCPH1 cooperates with E2F1 by interacting with it on the promoters of CHK1, BRCA1, RAD51, DDB2, TOPBP1, p73, and caspase genes to activate DNA repair, checkpoint, and apoptosis pathways; MCPH1 forms oligomers through its second and third BRCT domains. |
Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), promoter reporter assays, dominant-negative mutant analysis |
EMBO reports |
High |
18660752
|
| 2009 |
After DNA damage, BRIT1/MCPH1 increases its interaction with the SWI-SNF chromatin remodeling complex (specifically BAF170 subunit) through ATM/ATR-dependent phosphorylation of BAF170; BRIT1 recruits SWI-SNF to DNA lesions to promote chromatin relaxation and facilitate DNA repair. |
Co-immunoprecipitation, chromatin fractionation, RNAi knockdown, chromatin relaxation assay |
Nature cell biology |
High |
19525936
|
| 2009 |
The N-terminal BRCT domain of MCPH1 contains a hydrophobic pocket (adjacent to an elongated β1-α1 loop) that is required to prevent premature chromosome condensation; mutations in this pocket abrogate rescue of PCC in MCPH1-/- MEFs; the disease-associated T27R mutation resides in this domain. |
X-ray crystallography (1.6 Å resolution), site-directed mutagenesis, complementation assay in Mcph1-/- MEFs |
Journal of molecular biology |
High |
19925808
|
| 2010 |
BRIT1/MCPH1 knockout mice are hypersensitive to γ-irradiation, exhibit severe chromatid breaks, reduced RAD51 foci, impaired meiotic homologous recombination, and infertility; BRIT1 binds RAD51/BRCA2 complexes and its absence impairs chromatin recruitment of RAD51 and BRCA2. |
Knockout mouse model, irradiation sensitivity, metaphase spread, RAD51 foci, meiotic chromosome analysis, Co-immunoprecipitation |
PLoS genetics |
High |
20107607
|
| 2010 |
MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification; Mcph1-deficient DT40 cells show massive centrosome amplification after IR with sustained Chk1 phosphorylation and dysregulated Cdk2 activity, suggesting MCPH1 controls centrosome numbers after DNA damage. |
Mcph1 knockout in DT40 cells, light and electron microscopy of centrosomes, Western blot for pChk1 and Cdk2 activity |
Oncogene |
Medium |
20661222
|
| 2011 |
MCPH1 deletion in mice causes primary microcephaly through premature switching of neuroprogenitors from symmetric to asymmetric division; MCPH1 deficiency abrogates Chk1 localization to centrosomes, causing premature Cdk1 activation and early mitotic entry, which uncouples mitosis from the centrosome cycle and misorients the mitotic spindle; silencing Cdc25b rescues spindle misalignment and premature neurogenesis in Mcph1-KO neocortex. |
Conditional knockout mice, centrosome immunofluorescence, spindle orientation analysis, Chk1 localization assay, in vivo Cdc25b shRNA rescue |
Nature cell biology |
High |
21947081
|
| 2011 |
An N-terminal domain of hMCPH1 specifically inhibits condensin II by competing for its chromosomal binding sites in vitro; the central domain of hMCPH1 plays an auxiliary role in shaping metaphase chromosomes by physically interacting with condensin II; the N-terminal domain alone is sufficient to rescue the PCC phenotype in patient cells. |
Xenopus laevis egg extract cell-free condensation assay, patient cell complementation, domain deletion analysis |
The Journal of cell biology |
High |
21911480
|
| 2011 |
SET nuclear oncogene is a direct binding partner of the MCPH1 N-terminal BRCT domain; SET knockdown causes abnormal chromosome condensation similar to MCPH1-deficient cells; condensin II knockdown rescues SET-depleted chromosome condensation phenotype; MCPH1 V50G/I51V missense mutations impair SET binding and fail to rescue PCC in Mcph1-/- MEFs. |
Co-immunoprecipitation, RNAi knockdown, complementation in Mcph1-/- MEFs, epistasis with condensin II |
The Journal of biological chemistry |
High |
21515671
|
| 2011 |
VIP blockade during neurogenesis specifically downregulates Mcph1 expression, leading to downregulation of Chk1 and reduction of Chk1 kinase activity; in vitro silencing of either Mcph1 or Chk1 in neurospheres mimics VIP antagonist-induced inhibition of cell proliferation, placing MCPH1 in a VIP/MCPH1/Chk1 signaling axis. |
Quantitative RT-PCR, Western blot, Chk1 kinase assay, siRNA knockdown in neurospheres |
The Journal of clinical investigation |
Medium |
21737879
|
| 2011 |
Crystal structure of MCPH1 C-terminal tandem BRCT domains in complex with a γH2AX tail reveals binding selectivity for pSer+3 and preference for phosphopeptide with free COOH-terminus; fluorescence polarization assays confirm the binding parameters. |
X-ray crystallography, fluorescence polarization binding assay |
Journal of structural biology |
High |
22154951
|
| 2011 |
MCPH1 C-terminal tandem BRCT domains bind Cdc27, a component of the APC/C, in a phosphorylation-dependent manner; crystal structure of MCPH1 C-BRCTs in complex with phosphorylated Cdc27 peptide was determined; interface mutations disrupt the interaction. |
X-ray crystallography, in vitro and in vivo binding assays, site-directed mutagenesis |
The Journal of biological chemistry |
High |
22139841
|
| 2012 |
MCPH1 tandem BRCT domains can simultaneously read both pSer139 and pTyr142 modifications on H2A.X; structural, biochemical, and cellular evidence shows MCPH1 is recruited to DNA damage sites via both states of H2A.X phosphorylation. |
Crystal structure, biochemical binding assays, cellular recruitment analysis |
Proceedings of the National Academy of Sciences of the United States of America |
High |
22908299
|
| 2012 |
MCPH1 encodes two major isoforms (full-length MCPH1-FL and MCPH1Δe9-14) with distinct regulation; both isoforms have nuclear localization mediated by separate NLS motifs and both complement the chromosome condensation defect in MCPH1-deficient cells; MCPH1-FL but not the short isoform localizes to γH2AX foci after irradiation. |
RT-PCR isoform characterization, nuclear localization assay, siRNA complementation, immunofluorescence after irradiation |
PloS one |
Medium |
22952573
|
| 2014 |
Drosophila MCPH1-B isoform is a substrate of APC/CCdh1 E3 ubiquitin ligase; degradation requires an N-terminal D-box motif; dMCPH1-B is directly ubiquitinated by reconstituted APC(Cdh1) in vitro; overexpression of hMCPH1 in Xenopus embryos disrupts cell division. |
Xenopus egg extract degradation assay, D-box mutagenesis, reconstituted ubiquitination assay, Xenopus embryo overexpression |
Biology open |
High |
24972868
|
| 2015 |
BRIT1/MCPH1 is K63-ubiquitinated in unstimulated cells; BRUCE acts as a scaffold bridging USP8 and BRIT1 to form a nuclear complex; BRUCE promotes USP8-catalyzed deubiquitination of BRIT1 as a prerequisite for BRIT1 recruitment to DSB sites via γ-H2AX; loss of BRUCE or USP8 impairs BRIT1 deubiquitination and foci formation. |
Co-immunoprecipitation, ubiquitination assay, foci formation analysis, homologous recombination repair assay, BRUCE-mutant mouse model |
Proceedings of the National Academy of Sciences of the United States of America |
High |
25733871
|
| 2015 |
BRUCE UBC domain (E3 ligase activity) is required for USP8-mediated deubiquitination of BRIT1 and its subsequent recruitment to DSBs; UBC domain mutation does not disrupt BRUCE-USP8-BRIT1 complex formation but impairs deubiquitination and DSB signaling. |
Domain mutagenesis, Co-immunoprecipitation, ubiquitination assay, HR repair assay |
PloS one |
Medium |
26683461
|
| 2013 |
BRIT1/MCPH1 regulates p53 protein stability by blocking MDM2-mediated ubiquitination of p53; knockdown of BRIT1 in normal breast epithelial cells caused oncogenic transformation. |
Co-immunoprecipitation, ubiquitination assay, p53 stability assay, cellular transformation assay |
Carcinogenesis |
Medium |
23729656
|
| 2014 |
BRIT1 phosphorylation at Ser-322 (by ATM or ATR upon replication stress) facilitates efficient recruitment of TopBP1, a key ATR activator, to DNA damage sites; BRIT1 is dispensable for initiation but essential for amplification of ATR signaling. |
Co-immunoprecipitation, phospho-mutant analysis, TopBP1 recruitment assay, ATR signaling assays |
The Journal of biological chemistry |
Medium |
25301947
|
| 2017 |
MCPH1 interacts with and promotes E3 ligase βTrCP2 to degrade Cdc25A independent of DNA damage; this controls mitotic entry of neuroprogenitors; MCPH1 itself is degraded by APC/CCdh1 (not APC/CCdc20) in late mitosis and G1; forced MCPH1 expression causes cell death, showing importance of its timely degradation. |
Co-immunoprecipitation, Cdc25A degradation assay, neuroprogenitor in vivo rescue experiments, APC/C substrate specificity assay |
The EMBO journal |
High |
29150431
|
| 2017 |
BRIT1 is recruited to the Ig heavy chain locus in a γH2AX- and AID-dependent fashion via its C-terminal tandem BRCT domains binding phospho-H2AX; BRIT1 deficiency leads to increased unrepaired Ig breaks and reduced class switch recombination in B cells. |
Conditional knockout mouse, ChIP, CSR assay, Co-IP, tandem BRCT domain mutant analysis |
Proceedings of the National Academy of Sciences of the United States of America |
High |
28724724
|
| 2018 |
Both MCPH1 isoforms are phosphorylated by CDK1 during mitosis at several novel sites; upon mitotic exit, both isoforms are degraded by APC/C-CDH1 through distinct degron sequences: the long isoform via a D-box, and the short isoform via a KEN-box. |
Mass spectrometry phosphorylation mapping, CDK1 inhibitor treatment, APC/C degron mutagenesis, cell-cycle synchronization |
FASEB journal |
Medium |
30303738
|
| 2019 |
MCPH1 function is dispensable for activation and maintenance of the decatenation checkpoint but is required for the adaptive bypass of the topoisomerase II inhibition-mediated G2 arrest; MCPH1 does not confer adaptation to ATM/ATR-based DNA damage checkpoint. |
MCPH1-depleted HeLa cells, live-cell imaging of mitotic entry, topoisomerase II inhibitor treatment, checkpoint escape analysis |
FASEB journal |
Medium |
30964711
|
| 2020 |
MCPH1 is a bona fide DNA-binding protein; it directly interacts with RAD51 at multiple contact points and enhances the stability of RAD51-ssDNA filaments approximately 2-fold as measured by single-molecule tethered particle motion analysis. |
Purified recombinant protein, DNA-binding assay, Co-immunoprecipitation, single-molecule tethered particle motion analysis |
Nucleic acids research |
High |
32735676
|
| 2020 |
MCPH1/BRIT1 specifically interacts with the TRFH domain of TRF2 through its 330YRLSP334 motif; TRF2-dependent MCPH1 recruitment promotes DNA repair at dysfunctional telomeres and facilitates telomere replication fork progression and restart of stalled telomere replication forks. |
Crystal structure of MCPH1-TRF2 complex, Co-immunoprecipitation, telomere FISH, single-molecule DNA fiber analysis |
Nature communications |
High |
33203878
|
| 2020 |
Loss of MCPH1 causes CDK2-dependent increase in STIL levels at the centrosome, driving centrosome amplification; MCPH1 deep deletions are found in 5–15% of human cancers. |
TCGA genomic analysis, in cellulo MCPH1 knockdown, STIL centrosome quantification, CDK2 inhibitor rescue |
Scientific reports |
Medium |
32681070
|
| 2021 |
MCPH1 inhibits condensin II during interphase by binding a short linear motif within MCPH1 to condensin II's NCAPG2 subunit; deletion of Mcph1 in mouse ES cells unleashes condensin II, causing compact chromosomes in G1/G2 even without CDK1 activity and enhancing A/B compartment mixing; fusion of SMC2 with NCAPH2 abrogates MCPH1's inhibitory effect, suggesting a mechanism analogous to WAPL-mediated cohesin regulation. |
Mouse ES cell Mcph1 deletion, Hi-C chromatin conformation, CDK1 inhibition, SMC2-NCAPH2 fusion rescue experiment, NCAPG2 binding assay |
eLife |
High |
34850681
|
| 2021 |
The N-terminal BRCT domain of MCPH1 is essential for brain size regulation and gonad development in vivo; Mcph1-ΔBR1 mouse MEFs exhibit PCC phenotype and defective DNA damage response/repair; N-terminal BRCT deletion recapitulates all phenotypes of complete Mcph1 knockout. |
Mouse model with N-terminal BRCT deletion (Mcph1-ΔBR1), brain size measurement, fertility analysis, MEF PCC assay, DNA damage response assays |
Cell death & disease |
High |
33542216
|
| 2022 |
MCPH1 central domain (encoded by exon 8) interacts with E3 ligase βTrCP2 and is required for G2/M transition; Mcph1-Δe8 mice show reduced brain size, thinner cortex, sterility, and PCC phenotype in MEFs, demonstrating the central domain's essential role. |
Mouse model with exon 8 deletion, brain morphology analysis, germ cell analysis, MEF PCC assay, Co-immunoprecipitation |
Cells |
High |
36078123
|
| 2015 |
MCPH1 maintains epigenetic silencing of ANGPT2 in CLL by binding to the ANGPT2 promoter and recruiting DNA methyltransferases; MCPH1 knockdown results in ANGPT2 upregulation accompanied by loss of promoter methylation. |
Chromatin immunoprecipitation, co-immunoprecipitation, siRNA knockdown, bisulfite methylation analysis |
The FEBS journal |
Medium |
25703238
|
| 2024 |
In hematopoietic stem cells, MCPH1 exists in both nuclear and cytoplasmic pools; in the cytoplasm it prevents necroptosis by binding p-RIPK3; aging triggers KAT7-mediated lysine acetylation within the NLS motif of MCPH1, facilitating its nuclear translocation, reducing cytoplasmic MCPH1, and thereby activating necroptosis. |
HSC fractionation, Co-immunoprecipitation with p-RIPK3, KAT7 acetylation assay, NLS lysine mutant analysis, necroptosis assay |
Nature aging |
High |
38632351
|
| 2024 |
Mcph1 knockout in mice causes p19ARF upregulation in MEFs leading to cell cycle arrest and cellular senescence; silencing p19Arf restores cell cycle and growth arrest to wild-type levels, placing p19ARF downstream of MCPH1 loss. |
Mcph1 knockout MEFs, RNA-seq, p19Arf siRNA epistasis, cell cycle and senescence assays |
International journal of molecular sciences |
Medium |
38731817
|
| 2012 |
MCPH1 represses hTERT transcription by directly binding to the proximal hTERT promoter; overexpression of MCPH1 represses telomerase activity, and MCPH1 knockdown abolishes this repression. |
EMSA, luciferase promoter assay, siRNA knockdown, telomerase activity assay |
Gene |
Medium |
22240313
|